These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
53 related articles for article (PubMed ID: 150129)
1. [Ways to improve the early detection of bladder cancer patients (based on Grodno Province data)]. Nechiporenko AZ; Bogdanovich FA; Nechiporenko NA Vopr Onkol; 1978; 24(6):90-4. PubMed ID: 150129 [TBL] [Abstract][Full Text] [Related]
2. [The value of urine sediment cytomorphology in the ambulatory differential diagnosis of hematuria]. Obroniecka I; Rojewska J; Wańkowicz Z Pol Merkur Lekarski; 1998 Nov; 5(29):285-7. PubMed ID: 10101502 [TBL] [Abstract][Full Text] [Related]
3. Can hematuria be a predictor as well as a symptom or sign of bladder cancer? Friedman GD; Carroll PR; Cattolica EV; Hiatt RA Cancer Epidemiol Biomarkers Prev; 1996 Dec; 5(12):993-6. PubMed ID: 8959322 [TBL] [Abstract][Full Text] [Related]
4. Screening and monitoring for bladder cancer: refining the use of NMP22. Ponsky LE; Sharma S; Pandrangi L; Kedia S; Nelson D; Agarwal A; Zippe CD J Urol; 2001 Jul; 166(1):75-8. PubMed ID: 11435827 [TBL] [Abstract][Full Text] [Related]
5. Do patients with frank haematuria referred under the two-week rule have a higher incidence of bladder cancer? Thiruchelvam N; Mostafid H Ann R Coll Surg Engl; 2005 Sep; 87(5):345-7. PubMed ID: 16176693 [TBL] [Abstract][Full Text] [Related]
6. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion]. Słojewski M Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306 [TBL] [Abstract][Full Text] [Related]
7. Dipstick urinalysis screening, asymptomatic microhematuria, and subsequent urological cancers in a population-based sample. Hiatt RA; Ordoñez JD Cancer Epidemiol Biomarkers Prev; 1994; 3(5):439-43. PubMed ID: 7848421 [TBL] [Abstract][Full Text] [Related]
8. [The organization of the diagnosis and treatment of patients with bladder tumors in Rostov Province]. Polianichko MF; Zaderin VP Urol Nefrol (Mosk); 1997; (6):38-40. PubMed ID: 9461787 [TBL] [Abstract][Full Text] [Related]
9. Comparative study on the prevalence of clinically detectable prostate cancer in patients with and without bladder cancer. Kurokawa K; Ito K; Yamamoto T; Takechi H; Miyamoto S; Suzuki K; Yamanaka H Urology; 2004 Feb; 63(2):268-72. PubMed ID: 14972469 [TBL] [Abstract][Full Text] [Related]
10. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors. Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289 [TBL] [Abstract][Full Text] [Related]
11. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association. Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T; Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609 [TBL] [Abstract][Full Text] [Related]
12. Surveillance of urothelial carcinoma: stage and grade migration, 1993-2005 and survival trends, 1993-2000. David KA; Mallin K; Milowsky MI; Ritchey J; Carroll PR; Nanus DM Cancer; 2009 Apr; 115(7):1435-47. PubMed ID: 19215030 [TBL] [Abstract][Full Text] [Related]
13. NMP22 is a sensitive, cost-effective test in patients at risk for bladder cancer. Zippe C; Pandrangi L; Agarwal A J Urol; 1999 Jan; 161(1):62-5. PubMed ID: 10037369 [TBL] [Abstract][Full Text] [Related]
14. [A further study on potential of microsatellite analysis of urine in diagnosis of bladder cancer]. Zhang J; Zheng S; Di X Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(20):1224-6. PubMed ID: 11825522 [TBL] [Abstract][Full Text] [Related]
15. Long-term outcome of hematuria home screening for bladder cancer in men. Messing EM; Madeb R; Young T; Gilchrist KW; Bram L; Greenberg EB; Wegenke JD; Stephenson L; Gee J; Feng C Cancer; 2006 Nov; 107(9):2173-9. PubMed ID: 17029275 [TBL] [Abstract][Full Text] [Related]
16. NMP22: a sensitive, cost-effective test in patients at risk for bladder cancer. Zippe C; Pandrangi L; Potts JM; Kursh E; Novick A; Agarwal A Anticancer Res; 1999; 19(4A):2621-3. PubMed ID: 10470205 [TBL] [Abstract][Full Text] [Related]
17. De novo muscle invasive bladder cancer: is there a change in trend? Vaidya A; Soloway MS; Hawke C; Tiguert R; Civantos F J Urol; 2001 Jan; 165(1):47-50; discussion 50. PubMed ID: 11125361 [TBL] [Abstract][Full Text] [Related]
18. Urinary vascular endothelial growth factor and its correlation with bladder cancer recurrence rates. Crew JP; O'Brien T; Bicknell R; Fuggle S; Cranston D; Harris AL J Urol; 1999 Mar; 161(3):799-804. PubMed ID: 10022687 [TBL] [Abstract][Full Text] [Related]
19. Bladder cancer in renal transplant recipients. Buzzeo BD; Heisey DM; Messing EM Urology; 1997 Oct; 50(4):525-8. PubMed ID: 9338726 [TBL] [Abstract][Full Text] [Related]
20. Urological implications of concurrent bladder and lung cancer. Vainrib M; Leibovitch I Isr Med Assoc J; 2007 Oct; 9(10):732-5. PubMed ID: 17987763 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]